NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

NCT04167085 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Epistaxis

Interventions

DRUG: Doxycycline
OTHER: Placebo

Sponsor

University of California, Los Angeles